Edgewise Therapeutics logo

Edgewise Therapeutics Share Price (NASDAQ: EWTX)

$14.36

-0.29

(-1.98%)

Last updated on

Check the interactive Edgewise Therapeutics Stock chart to analyse performance

Edgewise Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$14.14
    Today's High:$14.38

    Day's Volatility :1.67%

  • 52 Weeks Low:$10.60
    52 Weeks High:$38.12

    52 Weeks Volatility :72.19%

Edgewise Therapeutics Stock Returns

PeriodEdgewise Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-2.31%
3.6%
0.0%
6 Months
-43.79%
-7.7%
0.0%
1 Year
-19.74%
-12.6%
0.0%
3 Years
36.41%
10.2%
-4.1%

Edgewise Therapeutics Inc Key Stats

Check Edgewise Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$14.65
Open
$14.29
Today's High
$14.38
Today's Low
$14.14
Market Capitalization
$1.5B
Today's Volume
$670.5K
52 Week High
$38.12
52 Week Low
$10.6
Revenue TTM
$0.0
EBITDA
$-172.4M
Earnings Per Share (EPS)
$-1.56
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-27.41%

Stock Returns calculator for Edgewise Therapeutics Stock including INR - Dollar returns

The Edgewise Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edgewise Therapeutics investment value today

Current value as on today

₹85,597

Returns

₹14,403

(-14.4%)

Returns from Edgewise Therapeutics Stock

₹19,687 (-19.69%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Edgewise Therapeutics Stock

20%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Edgewise Therapeutics Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Edgewise Therapeutics Inc

  • Name

    Holdings %

  • Orbimed Advisors, LLC

    14.26%

  • RA Capital Management, LLC

    9.40%

  • Baker Bros Advisors LP

    6.94%

  • BlackRock Inc

    6.16%

  • Paradigm Biocapital Advisors LP

    5.83%

  • HHG PLC

    5.22%

Analyst Recommendation on Edgewise Therapeutics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Edgewise Therapeutics(by analysts ranked 0 to 5 stars)

Edgewise Therapeutics Share Price Target

What analysts predicted

Upside of 161.14%

Target:

$37.50

Current:

$14.36

Edgewise Therapeutics share price target is $37.50, a slight Upside of 161.14% compared to current price of $14.36 as per analysts' prediction.

Edgewise Therapeutics Stock Insights

  • Price Movement

    In the last 6 months, EWTX stock has moved down by -45.2%
  • EWTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 93.4%
  • EWTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 73.6%

Edgewise Therapeutics Technicals Summary

Sell

Neutral

Buy

Edgewise Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Edgewise Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Edgewise Therapeutics Inc logo
0.28%
-43.79%
-19.74%
36.41%
-49.79%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Edgewise Therapeutics Inc

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Organization
Edgewise Therapeutics
Employees
126
CEO
Dr. Kevin Koch Ph.D.
Industry
Healthcare

Key Management of Edgewise Therapeutics Inc

NameTitle
Dr. Kevin Koch Ph.D.
President, CEO & Director
Dr. Behrad Derakhshan Ph.D.
Chief Operating Officer
Dr. Joanne M. Donovan M.D., Ph.D.
Chief Medical Officer
Dr. Alan J. Russell Ph.D.
Co-Founder, Chief Scientific Officer & Director
Mr. R. Michael Carruthers
Chief Financial Officer
Mr. John R. Moore J.D.
General Counsel
Dr. Robert Blaustein M.D., Ph.D.
Chief Development Officer

Important FAQs about investing in EWTX Stock from India :

What is Edgewise Therapeutics share price today?

Edgewise Therapeutics share price today is $14.36 as on at the close of the market. Edgewise Therapeutics share today touched a day high of $14.38 and a low of $14.14.

What is the 52 week high and 52 week low for Edgewise Therapeutics share?

Edgewise Therapeutics share touched a 52 week high of $38.12 and a 52 week low of $10.60. Edgewise Therapeutics stock price today i.e. is closed at $14.36, lower by 62.33% versus the 52 week high.

How to invest in Edgewise Therapeutics Stock (EWTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edgewise Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edgewise Therapeutics Shares that will get you 0.1045 shares as per Edgewise Therapeutics share price of $14.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Edgewise Therapeutics Stock (EWTX) from India?

Indian investors can start investing in Edgewise Therapeutics (EWTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Edgewise Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Edgewise Therapeutics share’s latest price of $14.36 as on August 30, 2025 at 1:29 am IST, you will get 0.6964 shares of Edgewise Therapeutics. Learn more about fractional shares .

What are the returns that Edgewise Therapeutics has given to Indian investors in the last 5 years?

Edgewise Therapeutics stock has given -49.79% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?